Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)

Br J Haematol. 1992 Feb;80(2):254-6. doi: 10.1111/j.1365-2141.1992.tb08910.x.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Leukocyte Count / drug effects
  • Neutropenia / drug therapy*
  • Primary Myelofibrosis / chemically induced
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor